568591-86-6Relevant articles and documents
Ketoamide-based inhibitors of cysteine protease, cathepsin K: P3 modifications
Tavares, Francis X.,Deaton, David N.,Miller, Larry R.,Wright, Lois L.
, p. 5057 - 5068 (2007/10/03)
Osteoporosis is a disease characterized by skeletal fragility. Cathepsin K, a lysosomal cysteine protease, has been implicated in the osteoclast mediated bone resorption. Inhibitors of this protease could potentially treat this skeletal disease. The prese